LINE-1 RNA knockdown averts heterochromatin loss and ameliorates premature ageing phenotypes
L1 specific 2F-ANA ASO treatment ameliorates the hallmarks of ageing unveiling L1 RNA as a potential novel target for therapeutic approach to treat premature aging and possibly related syndromes.